Fujipream Corporation

As of March 31, 2026, Fujipream Corporation carries a market capitalization of 10.89B, placing it among publicly traded companies globally. Its enterprise value stands at 9.89B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Fujipream Corporation's next confirmed earnings release is scheduled for November 11, 2026.

As of March 31, 2026, Fujipream Corporation has 28.57M shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, Fujipream Corporation maintains a current ratio of 1.42, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended March 31, 2026.

As of the close on October 22, 2026, Fujipream Corporation's stock has declined approximately 0.93% over the past 52 weeks. The 50-day moving average sits at 339.46, while the 200-day moving average is 359.24.

As of March 31, 2026, Fujipream Corporation holds 4.84B in cash and equivalents against 3.85B in total debt, resulting in a net debt position of -1.02B. Total book value stands at 7.67B, with working capital of 2.51B providing operational flexibility.

Fujipream Corporation's most recent stock split took place on November 7, 2005 with a 1:3 split ratio.